10519 related articles for article (PubMed ID: 10905502)
1. Cytotoxic effects of 5-fluorocytosine on melanoma cells transduced with cytosine deaminase gene.
Lü H; Wu D; Wan Y; Gu B; Wang J
J Environ Pathol Toxicol Oncol; 2000; 19(1-2):9-12. PubMed ID: 10905502
[TBL] [Abstract][Full Text] [Related]
2. Culture of human tumor infiltrating lymphocytes in hollow fiber bioreactors.
Knazek RA; Wu YW; Aebersold PM; Rosenberg SA
J Immunol Methods; 1990 Feb; 127(1):29-37. PubMed ID: 2319140
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of BCG cell-wall skeletons (BCG-CWS) emulsified in squalane on tumor growth and metastasis in mice.
Yoo YC; Hata K; Lee KB; Azuma I
Arch Pharm Res; 2002 Aug; 25(4):522-7. PubMed ID: 12214866
[TBL] [Abstract][Full Text] [Related]
4. Proliferative, phenotypic and functional and molecular characteristics of tumour-infiltrating lymphocytes obtained from unselected patients with malignant melanomas and expanded in vitro in the presence of recombinant interleukin-2.
Melioli G; Guastella M; Semino C; Meta M; Pietra G; Ponte M; Queirolo P; Sertoli MR; Martini L; Reali UM
Melanoma Res; 1994 Apr; 4(2):127-33. PubMed ID: 8069098
[TBL] [Abstract][Full Text] [Related]
5. Development of immunogenic colorectal cancer cell lines for vaccination: expression of CD80 (B7.1) is not sufficient to restore impaired primary T cell activation in vitro.
Habicht A; Lindauer M; Galmbacher P; Rudy W; Gebert J; Schackert HK; Meuer SC; Moebius U
Eur J Cancer; 1995 Dec; 31A(13-14):2396-402. PubMed ID: 8652275
[TBL] [Abstract][Full Text] [Related]
6. Antiviral and antitumor compounds from tunicates.
Rinehart KL; Gloer JB; Wilson GR; Hughes RG; Li LH; Renis HE; McGovren JP
Fed Proc; 1983 Jan; 42(1):87-90. PubMed ID: 6681537
[TBL] [Abstract][Full Text] [Related]
7. Induction and repair of DNA lesions in cultured human melanoma cells exposed to a nitrogen-ion beam.
Eguchi K; Inada T; Yaguchi M; Satoh S; Kaneko I
Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Jul; 52(1):115-23. PubMed ID: 3496303
[TBL] [Abstract][Full Text] [Related]
8. Semiquantitative PCR of alpha2 and alpha4 integrin mRNA shows differential response to the transcriptional modulators TGF-beta1 and TPA.
Zhu YH; Vekemans S; Cassiman JJ
Cell Mol Biol (Noisy-le-grand); 1997 Dec; 43(8):1221-6. PubMed ID: 9489948
[TBL] [Abstract][Full Text] [Related]
9. Choroidal melanomas near the optic disk or macula. Long-term results after proton beam irradiation: a report of 3 cases.
Zehetmayer M; Menapace R
Ophthalmologica; 1993; 206(1):18-23. PubMed ID: 8278155
[TBL] [Abstract][Full Text] [Related]
10. Activation of cellular cytotoxicity and complement-mediated lysis of melanoma and neuroblastoma cells in vitro by murine antiganglioside antibodies MB 3.6 and 14.G2a.
Mayer P; Handgretinger R; Bruchelt G; Schaber B; Rassner G; Fierlbeck G
Melanoma Res; 1994 Apr; 4(2):101-6. PubMed ID: 8069095
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-7 induces differential lymphokine-activated killer cell activity against human melanoma cells, keratinocytes, and endothelial cells.
Schadendorf D; Böhm M; Möller P; Grünewald T; Czarnetzki BM
J Invest Dermatol; 1994 Jun; 102(6):838-42. PubMed ID: 8006445
[TBL] [Abstract][Full Text] [Related]
12. Neuroectodermal tumor and monoclonal antibodies.
Helson L; Weinberger C; Helson C; Lieberman P
Am J Pediatr Hematol Oncol; 1984; 6(3):227-31. PubMed ID: 6097134
[TBL] [Abstract][Full Text] [Related]
13. [Effect of laser irradiation on transplantable melanoma].
Deviatkov ND; Pletnev SD; Gorodilova VV; Papliian NP; Gol'bert ZV
Vopr Onkol; 1970; 16(9):59-64. PubMed ID: 5495104
[No Abstract] [Full Text] [Related]
14. Combined interferon and vinblastine treatment of advanced melanoma: evaluation of the treatment results and the effects of the treatment on immunological functions.
Kellokumpu-Lehtinen P; Nordman E; Toivanen A
Cancer Immunol Immunother; 1989; 28(3):213-7. PubMed ID: 2784356
[TBL] [Abstract][Full Text] [Related]
15. Effect of retinoic acid on the infiltration of murine melanoma cells into the type I collagen gel.
Kono T; Furukawa M; Tanii T; Taniguchi S; Mizuno N; Ishii M; Hamada T
Acta Derm Venereol; 1991; 71(1):41-4. PubMed ID: 1676213
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant high-dose interferon-alpha therapy for high-risk melanoma.
Kirkwood JM; Tarhini AA
Forum (Genova); 2003; 13(2):127-40; quiz 187-8. PubMed ID: 14732880
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen and quercetin interact with type II estrogen binding sites and inhibit the growth of human melanoma cells.
Piantelli M; Maggiano N; Ricci R; Larocca LM; Capelli A; Scambia G; Isola G; Natali PG; Ranelletti FO
J Invest Dermatol; 1995 Aug; 105(2):248-53. PubMed ID: 7636308
[TBL] [Abstract][Full Text] [Related]
18. Tumor growth rate varies with age in lethargic mutant BALB/cGnDu mice.
Morrison DG; Moyer MP; Dung HC; Rogers W; Moyer RC
Dev Comp Immunol; 1984; 8(2):435-42. PubMed ID: 6734874
[TBL] [Abstract][Full Text] [Related]
19. Trametinib.
Zeiser R
Recent Results Cancer Res; 2014; 201():241-8. PubMed ID: 24756797
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of the melanoma antigen gene (MAGE) in making the differential diagnosis between pleomorphic adenoma and adenoid cystic carcinoma.
Park JH; Do NY; Han SI; Lim SC
J Otolaryngol Head Neck Surg; 2012 Feb; 41(1):20-9. PubMed ID: 22498264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
